# Efficiency of Levamisole for Maintaining Remission After the First Flare of Steroid Sensitive Nephrotic Syndrome in Children

> **NCT02818738** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 86 (actual)

## Conditions studied

- First Manifestation of Steroid Sensitive Nephrotic Syndrome

## Interventions

- **DRUG:** Levamisole Hydrochloride
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02818738
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-06
- **Primary completion:** 2021-02-07
- **Final completion:** 2021-02-11
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2022-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02818738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02818738, "Efficiency of Levamisole for Maintaining Remission After the First Flare of Steroid Sensitive Nephrotic Syndrome in Children". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT02818738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*